EC Healthcare published its monthly return of movements in securities for the period ended 31 January 2026. The authorized share capital remains at 38,000,000,000 ordinary shares, with a par value of HKD 0.00001 each, totaling HKD 380,000. The issued share capital is unchanged at 1,185,211,265 ordinary shares, and there were no treasury shares. The company confirms compliance with the 25% public float requirement.

Two share option schemes are in place, with 18,962,500 options outstanding under one scheme approved on 19 February 2016 and 59,260,563 outstanding under another approved on 29 May 2023. No new shares were issued from these options during the month.

Warrants in the amount of HKD 36,400,000 are outstanding at a subscription price of HKD 6.17, allowing the issue of up to 5,899,513 shares if exercised before 8 February 2026. Convertible bonds include HKD 234,000,000 in GS Convertible Bonds at a conversion price of HKD 5.639379 (potentially 41,493,930 shares) and HKD 31,200,000 in OrbiMed Convertible Bonds at a conversion price of HKD 5.69 (potentially 5,483,304 shares). No new shares were issued under these warrants or convertible bonds during January 2026.